The global fetal monitoring market is expected to register growth over the forecast period. Increasing prevalence of cardiopulmonary diseases, technological advancement such as noninvasive surgeries, increasing government and non-government initiatives for maternal & fetal health over the world, rising manufactures awareness & willingness to invest in the development of fetal monitoring, and increase in the number of post-term pregnancy, multiple pregnancy, and premature delivery cases, are few factors that are driving the global fetal monitoring market. This market includes fetal heart rate, fetal movement, and uterine contraction examining devices. However, the high cost of equipment, lack of intervening guidelines, technological limitations, and subjective interpretations are few factors that may hinder the growth of the global market of fetal monitoring.
On the basis of products, the fetal monitoring market is classified into instruments & consumables, which is further subdivided into ultrasound & ultrasonography, electronic fetal monitoring, fetal electrodes, fetal Doppler, uterine contraction monitor, telemetry solutions, accessories & consumables, and software. Instrument and consumables reported to have the largest share of the market. Key factors attributing to its lucrative growth include increasing maternal mortality rate, defect in birthrate, and favorable government organizations initiatives to improve parental care, antepartum hemorrhage rate, premature delivery rate, and technologically advancement. On the method basis, the market is segmented into invasive and non-invasive methods. On the basis of portability, the market is divided into portable and non portable systems. Non-portable systems are expected to grow at a lucrative growth over the forecast period owing to increasing government and non-government initiatives regarding maternal mortality across the world, and preeclampsia in mother during pregnancy. Antepartum and intrapartum are the key application areas analyzed in the scope of the study. On the basis of end use the market is segmented into hospitals, clinics, and others. In the application segment, antepartum established to be the largest growing market, wherein the end-user segment, the hospital is the major segment in this market.
North America, Asia Pacific, Europe, MEA, and Latin America are amongst the key regional market included in the study. North America emerged as one of the largest revenue-generating region in the fetal monitoring market which is contributed by several factors such as technological advancements, rising patient awareness levels, and better reimbursement policies. It is estimated that it will persist to be in that position over the forecasted period. However, Asia Pacific is expected to grow at a lucrative CAGR over the forecast period. Key factors attributing for its lucrative growth include increasing per capita income, constant development in healthcare infrastructure, and favorable government initiative towards the development of healthcare infrastructure.
Key players operating in the fetal monitoring market include Covidien PLC, FUJIFILM SonoSite, Inc., GE Healthcare, Natus, Philips Healthcare, Siemens Healthcare, Neoventa Medical, Spacelabs Healthcare, Inc., Analogic Corporation and ArjoHuntleigh, Inc.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.